Navigation Links
OpenQ is Awarded Prestigious Life Sciences Industry Award

OpenQ wins the 2009 Global Pharmaceutical CRM Growth Strategy Leadership of the Year presented by Frost & Sullivan

Charlottesville, VA, New York, NY and Paris, France (PRWEB) June 15, 2009 -- OpenQ, one of the industry leaders in KOL management solutions and MSL performance tools, announces that it has received the prestigious 2009 Global Pharmaceutical CRM Growth Strategy Leadership of the Year award, presented by Frost & Sullivan to the company that has demonstrated an exceptional growth strategy within the industry.

A recipient is chosen to receive the Frost & Sullivan Award for CRM Growth Strategy Leadership of the Year based on specific criteria. Through primary and secondary research methods, all companies' market revenues are tracked and those exhibiting significant growth are noted for their strategy implementation. Revenues are then compared year to year to monitor growth patterns. When a company consistently shows high growth rates, it is a candidate for the Frost & Sullivan Award Growth Strategy Leadership of the Year.

This accolade is given to the company that has bolstered their position in the market during the base year and whose strategy will have a profound and lasting impact on the market. The award criteria consist of the following:

  • Ability to grow in a saturated or maturing market
  • Implementing a unique sales strategy
  • Technological innovation and leadership
  • Discovering new venues for an established product
  • Effective Internet strategy
  • Strategic mergers, acquisitions, or joint ventures to penetrate new markets
  • Reorganization structured around growth strategy

About openQ:
OpenQ provides the integrated insights and software solutions to meet the critical compliance, KOL, content and speaker needs facing Life Science companies, from development stage through maturity. Achieving another year of exponential growth, openQ serves its customers from various locations across North America, South America, Europe and Asia. OpenQ's growing list of customers includes 7 of the Top 10 pharmaceutical and 3 of the Top 5 medical device companies. For more information, visit


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. DNA2.0 Awarded US Patents for Breakthrough Gene Optimization Technology -- Company's Unique Algorithm Enables Expression Yields up to 50 Times Greater than Competing Approaches
2. Proplant Awarded Qatar Project
3. Plexus Awarded Development Contract With QIAGEN
4. Enerkem GreenField Alberta Biofuels Awarded Permit to Build Worlds First Commercial Municipal Waste-to-Biofuels Facility
5. ChanTest Awarded $4.8 Million Through the Ohio Third Frontier Research and Commercialization Program
6. CeNeRx BioPharma Awarded New Patent for its Innovative Compounds That Selectively Target Peripheral Cannabinoid Receptors
7. ArunA Biomedical Awarded Department of Defense Contract to Further Develop Environmental Biosensor for National Security
8. Peregrine Pharmaceuticals Awarded New U.S. Patent Further Strengthening Its Anti-Phospholipid Patent Portfolio
9. PCI Biotech-led Consortium Awarded EUR1.1 m Eurostars Grant for siRNA
10. Transgenomic Awarded Clinical Laboratory Certification in California
11. OLIGOMERIX Awarded NIH Grant to Develop Novel Biomarkers for Alzheimers Disease
Post Your Comments:
Related Image:
OpenQ is Awarded Prestigious Life Sciences Industry Award
(Date:6/27/2016)... ... 27, 2016 , ... Cancer experts from Austria, Hungary, Switzerland, ... a new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma has just ... now. , Biomarkers are components in the blood, tissue or body fluids ...
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers ... 5000 and the 6000i models are higher end machines that use the more unconventional ... spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci has ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
Breaking Biology Technology:
(Date:5/9/2016)... -- Elevay is currently known as the ... high net worth professionals seeking travel for work   ... there is still no substitute for a face-to-face meeting. ... deal with a firm handshake. This is why wealthy ... citizenship via investment programs like those offered by the ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
(Date:4/19/2016)... , UAE, April 20, 2016 ... be implemented as a compact web-based "all-in-one" system solution ... the biometric fingerprint reader or the door interface with ... of modern access control systems. The minimal dimensions of ... ID readers into the building installations offer considerable freedom ...
Breaking Biology News(10 mins):